Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

Abstract

Human B cell stimulatory factor 2 (BSF-2) was originally charac-terized and isolated as a T cell-derived factor that caused the terminal maturation of activated B cells to immunoglobulin-producing cells1,2. Molecular cloning of the complementary DNA predicts that BSF-2 is a protein of relative molecular mass (Mr) 26,000 similar or identical to interferon β2, hybridoma plasmacytoma growth factor and hepatocyte stimulating factor3–7. IL-6 has been proposed as a name for this molecule8,9. It is now known that BSF-2 has a wide variety of biological functions and that its target cells are not restricted to normal B cells1,10. Responses are also seen in T cells11,12, plasmacytomas6, hepatocytes7,13, haematopoietic stem cells14, fibroblasts15 and rat phoeochromocytoma, PC 12 (Satoh, T. et al., manuscript in preparation). Of particular interest to this report is that human BSF-2 is a potent growth factor for murine plasmacytomas and hybridomas6,8,10. This observation suggested to us that constitutive expression of BSF-2 or its receptor could be responsible for the generation of human myelomas. In this study we report that myeloma cells freshly isolated from patients produce BSF-2 and express its receptors. Moreover, anti-BSF-2 antibody inhibits the in vitro growth of myeloma cells. This is direct evidence that an autocrine loop is operating in oncogenesis of human myelomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hirano, T. et al. Proc. natn. Acad. Sci. U.S.A. 82, 5490–5494 (1985).

    Article  ADS  CAS  Google Scholar 

  2. Hirano, T. et al. Proc. natn. Acad. Sci. U.S.A. 84, 228–231 (1987).

    Article  ADS  CAS  Google Scholar 

  3. Hirano, T. et al. Nature 324, 73–76 (1986).

    Article  ADS  CAS  Google Scholar 

  4. Haegeman, G., Content, J., Volckaert, G., Derynck, R., Tavernier, J. & Fiers, W. Eur. J. Biochem. 159, 625–632 (1986).

    Article  CAS  Google Scholar 

  5. Zilberstein, A., Ruggieri, R., Korn, J. H. & Revel, M. EMBO J. 5, 2529–2537 (1986).

    Article  CAS  Google Scholar 

  6. Van Damme, J. et al. J. exp. Med. 165, 914–919 (1987).

    Article  CAS  Google Scholar 

  7. Andus, T. et al.1 FEBS Lett. 221, 18–22 (1987).

    Article  CAS  Google Scholar 

  8. Poupart, P. et al. EMBO J. 6, 1219–1224 (1987).

    Article  CAS  Google Scholar 

  9. Yasukawa, K. et al. EMBO J. 6, 2939–2945 (1987).

    Article  CAS  Google Scholar 

  10. Muraguchi, A. et al. J. exp. Med. (in the press).

  11. Garman, R. D., Jacobs, K. A., Clark, S. C. & Raulet, D. H. Proc. natn. Acad. Sci. U.S.A. 84, 7629–7633 (1987).

    Article  ADS  CAS  Google Scholar 

  12. Lotz, M. et al. J. exp. Med. (in the press).

  13. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P. & Baumann, H. Proc. natn. Acad. Sci. U.S.A. 84, 7251–7255 (1987).

    Article  ADS  CAS  Google Scholar 

  14. Ikebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y. & Ogawa, M. Proc. natn. Acad. Sci. U.S.A. (in the press).

  15. Kohase, M., Henriksen-DeStefano, D., May, L. T., Vilcek, J. & Sehgal, P. B. Cell 45, 659–666 (1986).

    Article  CAS  Google Scholar 

  16. Durie, B. G. & Salmon, S. E. Cancer 36, 842–854 (1975).

    Article  CAS  Google Scholar 

  17. Kawano, M., Fujimura, K., Iwato, K., Asaoku, H., Tanabe, O. & Kuramoto, A. Acta Haemat. jap. 49, 1740–1748 (1986).

    CAS  PubMed  Google Scholar 

  18. Taga, T., Kawanishi, K., Hardy, R. R., Hirano, T. & Kishimoto, T. J. exp. Med. 166, 967–981 (1987).

    Article  CAS  Google Scholar 

  19. Potter, M. & Boyce, C. Nature 193, 1086–1087 (1962).

    Article  ADS  CAS  Google Scholar 

  20. Nordan, R. P. & Potter, M. Science 233, 566–569 (1986).

    Article  ADS  CAS  Google Scholar 

  21. Sporn, M. B. & Todaro, G. J. New Engl. J. Med. 303, 878–880 (1980).

    Article  CAS  Google Scholar 

  22. Sprm, M. B. & Roberts, A. B. Nature 313, 745–747 (1985).

    Article  ADS  Google Scholar 

  23. Huang, J. S., Huang, S. S. & Deuel, T. F. Cell 39, 79–87 (1984).

    Article  CAS  Google Scholar 

  24. Cuttitta, F. et al. Nature 316, 823–826 (1986).

    Article  ADS  Google Scholar 

  25. Hirano, T., Matsuda, T., Hosoi, K., Okano, A., Matsui, H. & Kishimoto, T. Immun. Lett. 17, 41–45 (1988).

    Article  CAS  Google Scholar 

  26. Chirwin, J. M., Przybla, A. E., MacDonald, R. L. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawano, M., Hirano, T., Matsuda, T. et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83–85 (1988). https://doi.org/10.1038/332083a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/332083a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing